Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
The Journal of Clinical Psychiatry
|
September 7, 2012
The transdermal delivery system of monoamine oxidase inhibitors
Chad M VanDenBerg
The Journal of Clinical Psychiatry
|
October 13, 2012
MAOIs and transdermal delivery
Chad M Vandenberg
Journal of Clinical Pharmacology
|
June 24, 2003
Tyramine pharmacokinetics and reduced bioavailability with food
Chad M VanDenBerg, Lawrence F Blob, Eva M Kemper, et al.
Journal of Clinical Pharmacology
|
February 2, 2008
Disposition of D-serine in healthy adults
Guochuan E Tsai, Hsien-Yuan Lane, Chad M Vandenberg, et al.
Journal of Clinical Pharmacology
|
June 8, 2007
Evaluation of the potential for pharmacodynamic and pharmacokinetic drug interactions between selegiline transdermal system and two sympathomimetic agents (pseudoephedrine and phenylpropanolamine) in healthy volunteers
Albert J Azzaro, Chad M VanDenBerg, John Ziemniak, et al.
CNS Spectrums
|
December 29, 2006
Effects of a tyramine-enriched meal on blood pressure response in healthy male volunteers treated with selegiline transdermal system 6 mg/24 hour
Lawrence F Blob, Melvin Sharoky, Bryan J Campbell, et al.
Journal of Clinical Pharmacology
|
July 21, 2006
Tyramine pressor sensitivity during treatment with the selegiline transdermal system 6 mg/24 h in healthy subjects
Albert J Azzaro, Chad M Vandenberg, Lawrence F Blob, et al.
Drug Metabolism and Drug Interactions
|
September 12, 2002
Pharmacokinetics of fluvoxamine in relation to CYP2C19 phenotype and genotype
Michael W Jan, Troy L ZumBrunnen, Yusuf R Kazmi, et al.
The Journal of Clinical Psychiatry
|
September 7, 2012
Discussion: a fresh look at monoamine oxidase inhibitors for depression
Lawrence J Cohen, David A Sclar, Larry Culpepper, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
The Journal of Clinical Psychiatry
|
September 7, 2012
The transdermal delivery system of monoamine oxidase inhibitors
Chad M VanDenBerg
The Journal of Clinical Psychiatry
|
October 13, 2012
MAOIs and transdermal delivery
Chad M Vandenberg
Journal of Clinical Pharmacology
|
June 24, 2003
Tyramine pharmacokinetics and reduced bioavailability with food
Chad M VanDenBerg, Lawrence F Blob, Eva M Kemper, et al.
Journal of Clinical Pharmacology
|
February 2, 2008
Disposition of D-serine in healthy adults
Guochuan E Tsai, Hsien-Yuan Lane, Chad M Vandenberg, et al.
Journal of Clinical Pharmacology
|
June 8, 2007
Evaluation of the potential for pharmacodynamic and pharmacokinetic drug interactions between selegiline transdermal system and two sympathomimetic agents (pseudoephedrine and phenylpropanolamine) in healthy volunteers
Albert J Azzaro, Chad M VanDenBerg, John Ziemniak, et al.
CNS Spectrums
|
December 29, 2006
Effects of a tyramine-enriched meal on blood pressure response in healthy male volunteers treated with selegiline transdermal system 6 mg/24 hour
Lawrence F Blob, Melvin Sharoky, Bryan J Campbell, et al.
Journal of Clinical Pharmacology
|
July 21, 2006
Tyramine pressor sensitivity during treatment with the selegiline transdermal system 6 mg/24 h in healthy subjects
Albert J Azzaro, Chad M Vandenberg, Lawrence F Blob, et al.
Drug Metabolism and Drug Interactions
|
September 12, 2002
Pharmacokinetics of fluvoxamine in relation to CYP2C19 phenotype and genotype
Michael W Jan, Troy L ZumBrunnen, Yusuf R Kazmi, et al.
The Journal of Clinical Psychiatry
|
September 7, 2012
Discussion: a fresh look at monoamine oxidase inhibitors for depression
Lawrence J Cohen, David A Sclar, Larry Culpepper, et al.
Page
of 1